• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION HOLLOW FIBER OXY WITH 3000 ML; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION HOLLOW FIBER OXY WITH 3000 ML; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*RX15RW30
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Information (3190)
Event Type  malfunction  
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
 
Event Description
The user facility reported to terumo cardiovascular that white bits on surface of the blood were observed.It is unknown when the event occurred, if there was a delay in the procedure, if the product was changed out, the results of the procedure or if there was any blood loss.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on november 11, 2019.Upon further investigation of the reported event, the following information is new and/or changed: g4 (date received by manufacturer) g7 (indication that this is a follow-up report) h2 (follow-up due to additional information) h6 (identification of evaluation codes (4119, 4114, 3221, 4315).Method code #1: 4119 - insufficient information available method code #2: 4114 - device not returned results code: 3221 - no findings available conclusions code: 4315 - cause not established.The affected sample was not returned for evaluation.However, pictures provided with the complaint confirmed the existence of white biological material.A root cause could not be determined as the lot number is unknown and the sample was not returned.There are potential patient conditions with different blood levels and combinations of triglycerides, high lipid concentrations and activated white cell levels due to inflammatory response that may have occurred and contributed to the event.It could also be the residual of a platelet/white cell, (white clot) event.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HOLLOW FIBER OXY WITH 3000 ML
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
MDR Report Key9306911
MDR Text Key168837563
Report Number1124841-2019-00308
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier00699753450127
UDI-Public(01)00699753450127
Combination Product (y/n)N
PMA/PMN Number
K151389
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 01/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number3CX*RX15RW30
Device Catalogue NumberN/A
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-